Home  »  Finance   »  Sabra Health Care REIT Inc. (SBRA) is down -6.09% ...

Sabra Health Care REIT Inc. (SBRA) is down -6.09% from 52 weeks low but Don’t Get Your Hopes high

Sabra Health Care REIT Inc. (NASDAQ:SBRA) shares fell to a low of $16.88 before closing at $17.16. Intraday shares traded counted 1.6 million, which was 18.47% higher than its 30-day average trading volume of 1.96M. SBRA’s previous close was $17.10 while the outstanding shares total 211.45M. The firm has a beta of 1.53, a 12-month trailing P/E ratio of 26.24, and a growth ratio of 4.37. The stock’s Relative Strength Index (RSI) is 41.26, with weekly volatility at 2.47% and ATR at 0.43. The SBRA stock’s 52-week price range has touched low of $11.07 and a $18.95 high. The stock traded higher over the last trading session, gaining 0.35% on 05/17/21.

Investors have identified the REIT – Healthcare Facilities company Sabra Health Care REIT Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $3.71 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.

Having a look at the company’s valuation, the company is expected to record 1.69 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on SBRA sounds very interesting.

Is the stock of SBRA attractive?

In related news, Director, Cusack Catherine bought 2,000 shares of the company’s stock in a transaction that recorded on May 13. The purchase was performed at an average price of 17.19, for a total value of 34,380. As the purchase deal closes, the Director, FOSTER MICHAEL J now sold 6,000 shares of the company’s stock, valued at 104,610. Also, Director, Cusack Catherine bought 1,000 shares of the company’s stock in a deal that was recorded on Mar 02. The shares were cost at an average price of 17.34 per share, with a total market value of 17,340. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.00%.

6 out of 14 analysts covering the stock have rated it a Buy, while 7 have maintained a Hold recommendation on Sabra Health Care REIT Inc.. 0 analysts has assigned a Sell rating on the SBRA stock. The 12-month mean consensus price target for the company’s shares has been set at $19.07.

Leave a Comment

Your email address will not be published. Required fields are marked *